Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Positive Start to the Day
Mon, 21 Mar 09:30 am

Barring Japan, major Asian stock markets have opened the day on a positive note. The stock markets in China and Taiwan are trading higher by 1.8% and 0.9% respectively. Major indices in Europe and US ended their previous session in green. The rupee is trading at 66.6 per US$.

Indian stock markets have opened the day on a firm note. The BSE Sensex is trading higher by 112 points (up 0.5%) and NSE Nifty is trading higher by 34 points (up 0.4%). Both, BSE Mid Cap and BSE Small Cap are trading higher by 0.3% and 0.5% respectively. Major sectoral indices have opened the day in green with stocks from banking and fast moving consumer goods (FMCG) sector witnessing maximum buying interest.

As per an article in a leading financial daily, Torrent Pharmaceutical plans to raise funds through various instruments including qualified institutional placements (QIP). However, the company did not specify the quantum of funds it intends to raise.

Further, the company has stated that its board on 23rd March will consider the proposal for raising funds by way of issue of equity shares, including convertible bonds or debentures through qualified institutional placements or any other modes.

Earlier, the company had stated that its third manufacturing plant in Gujarat had obtained the Establishment Inspection Report (EIR) from the US health regulator USFDA. With the approval, this plant is now the third plant of Torrent Pharma to receive the USFDA approval, out of its 5 manufacturing plants.

In the coming fiscal, Torrent has targeted to launch 7-8 products out of which 1-2 could be in niche segments. This is likely to be an important growth driver for the domestic business, going forward. The stock is trading up by 0.3%.

As per Business Standard, Dabur India published an article stating the virtues and positives of using its ayurvedic cough syrup named Dabur Honitus. This product is positioned as an alternative to other cough syrups, many of which have been banned by the government recently. The ban is to put a clampdown on fixed dose combination drugs (subscription required). Reportedly, the ban will dent the overall revenues of pharma players by 2-3%.

By publishing the article, Dabur has moved quickly to take advantage of the ban. Reportedly, other ayurvedic drug majors too could cash in by pushing their products in the market. Next week, the Ayurvedic Drug Manufacturers Association (ADMA), the apex body of the sector will meet in Mumbai. The manufacturers are expected to discuss their prospects to exploit this opportunity. It will be interesting to see how the ayurvedic players cash in on this huge opportunity going forward.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Positive Start to the Day". Click here!


Views on News

Why Rising Bond Yields Spooked the Market (Fast Profits Daily)

Mar 2, 2021

The stock market has been worried about rising bond yields recently and for good reason. In this video, I'll tell you why.

Bond Yields Are Surging. What Should Be Your Debt Funds Strategy (Outside View)

Mar 2, 2021

Bond Yields are surging. PersonalFN explains the outlook for Debt Markets and what should be your debt funds strategy in a rising interest rate scenario.

Such China Challenger Stocks are STILL Ignored and Undervalued (Profit Hunter)

Mar 2, 2021

Don't mistake defence stocks to be the only China challengers.

Beware the Ides of March (Fast Profits Daily)

Mar 1, 2021

The month of March is usually difficult for traders. This time it will be even more so. Find out why in this video.

UTI Nifty200 Momentum 30 Index Fund: Aims to Benefit from Momentum Investing Strategy (Outside View)

Mar 1, 2021

PersonalFN analyses the features of UTI Nifty200 Momentum 30 Index Fund and explains the potential this fund has to offer to its investors.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 2, 2021 (Close)